Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters
Language
Document Type
Year range
1.
alpha-1 Adrenergic receptor antagonists and risk of severe COVID-19
Smith, E.; Graham, D.; Izurieta, H.; Zhang, D.; Avagyan, A.; Lyu, H.; Wiederhorn, A.; Lu, Y.; Mosholder, A.; Zhao, Y. Q.; Shangguan, S.; Tsai, H. T.; Pennap, D.; Sandhu, A.; Wernecke, M.; MaCurdy, T. E.; Kelman, J.; Forshee, R. A..
Pharmacoepidemiology and Drug Safety ; 31:163-164, 2022.
Article in English | Web of Science | ID: covidwho-2084166
2.
Nursing home facility characteristics and occurrence of severe COVID-19 outcomes among US Medicare beneficiaries ages 65 and older in the vaccine era
Izurieta, H.; Menis, M.; Lu, Y.; Graham, D.; Jiao, Y. X.; Sung, H. M.; Wu, Y.; Chillarige, Y.; Wernecke, M.; Kelman, J.; Forshee, R. A..
Pharmacoepidemiology and Drug Safety ; 31:495-496, 2022.
Article in English | Web of Science | ID: covidwho-2083728
3.
Real-world effectiveness of MRNA COVID-19 vaccines among elderly US nursing home residents
Izurieta, H.; Lu, Y.; Lindaas, A.; Matuska, K.; Shi, X.; Menis, M.; Steele, W.; Wernecke, M.; Chillarige, Y.; Wong, H. L.; Kelman, J.; Forshee, R. A..
Pharmacoepidemiology and Drug Safety ; 31:483-483, 2022.
Article in English | Web of Science | ID: covidwho-2083727
4.
Natural history of COVID-19 among US nursing home residents ages > 65 years: Vaccine era
Izurieta, H.; Lu, Y.; Jiao, Y. X.; Graham, D.; Wernecke, M.; Menis, M.; Chillarige, Y.; Sung, H. M.; Wu, Y.; Kelman, J.; Forshee, R. A..
Pharmacoepidemiology and Drug Safety ; 31:502-502, 2022.
Article in English | Web of Science | ID: covidwho-2083726
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL